Page last updated: 2024-09-05

anacardic acid and Acute Confusional Senile Dementia

anacardic acid has been researched along with Acute Confusional Senile Dementia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Angeloni, C; Bartolini, M; Bergamini, C; Bolognesi, ML; Chantegreil, F; de Camargo Nascente, L; de Melo Viana Teixeira, S; Freschi, M; Hrelia, S; Malaguti, M; Nachon, F; Prchal, L; Rossi, M; Salerno, A; Soares Romeiro, LA; Soukup, O1
Alves, DR; da Silva, WMB; de Menezes, JESA; de Morais, SM; Magalhães, FEA; Marinho, ES; Marinho, MM; Pinheiro, SO; Silva, FCO1
Gargano, R; Kiametis, AS; Martins, JB; Romeiro, LA; Silva, MA1

Other Studies

3 other study(ies) available for anacardic acid and Acute Confusional Senile Dementia

ArticleYear
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.
    Journal of medicinal chemistry, 2021, 04-22, Volume: 64, Issue:8

    Topics: Acetylcholinesterase; Alzheimer Disease; Anacardium; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cell Line; Cell Survival; Cytokines; Drug Design; Humans; Ligands; Lipopolysaccharides; Microglia; Molecular Dynamics Simulation; Neuroprotective Agents; Nuts; Plant Extracts; Structure-Activity Relationship; Tacrine

2021
Anacardic Acid Complexes as Possible Agents Against Alzheimer's Disease Through Their Antioxidant, In vitro, and In silico Anticholinesterase and Ansiolic Actions.
    Neurotoxicity research, 2021, Volume: 39, Issue:2

    Topics: Alzheimer Disease; Anacardic Acids; Animals; Antioxidants; Chelating Agents; Cholinesterase Inhibitors; Copper; Molecular Docking Simulation; Zebrafish; Zinc

2021
Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction.
    Journal of molecular modeling, 2017, Volume: 23, Issue:2

    Topics: Acetylcholinesterase; Alzheimer Disease; Anacardic Acids; Anacardium; Cholinesterase Inhibitors; Drug Design; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation

2017